<?xml version="1.0" encoding="UTF-8"?>

<rootTag>
  <Award>
    <AwardTitle>STTR Phase I: An Advanced Antibiotic Screen of Marine Environmental DNA through a Metabolically Engineered E. coli Strain</AwardTitle>
    <AwardEffectiveDate>07/01/2007</AwardEffectiveDate>
    <AwardExpirationDate>12/31/2008</AwardExpirationDate>
    <AwardAmount>150000</AwardAmount>
    <AwardInstrument>
      <Value>Standard Grant</Value>
    </AwardInstrument>
    <Organization>
      <Code>07070000</Code>
      <Directorate>
        <LongName>Directorate For Engineering</LongName>
      </Directorate>
      <Division>
        <LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
      </Division>
    </Organization>
    <ProgramOfficer>
      <SignBlockName>Gregory T. Baxter</SignBlockName>
    </ProgramOfficer>
    <AbstractNarration>This Small Business Technology Transfer (STTR) Phase I research project aims to develop a new method for expressing novel antimicrobials from marine microbial DNA in engineered E. coli. &lt;br/&gt;&lt;br/&gt;Availability of new antibiotics would be of great value to medicine, as more human pathogens are acquiring resistance to mainstay antibiotic therapy. Moreover, a method for expression and isolation of heterologous natural products in E. coli would also open the door to identification of products with other desired activities, such as anti-tumorigenic compounds.</AbstractNarration>
    <MinAmdLetterDate>05/14/2007</MinAmdLetterDate>
    <MaxAmdLetterDate>08/13/2008</MaxAmdLetterDate>
    <ARRAAmount/>
    <AwardID>0712019</AwardID>
    <Investigator>
      <FirstName>Lance</FirstName>
      <LastName>Davidow</LastName>
      <EmailAddress>davidow@molbio.mgh.harvard.edu</EmailAddress>
      <StartDate>05/14/2007</StartDate>
      <EndDate>12/18/2007</EndDate>
      <RoleCode>Former Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>David</FirstName>
      <LastName>Rothstein</LastName>
      <EmailAddress>drothstein@rcn.com</EmailAddress>
      <StartDate>12/18/2007</StartDate>
      <EndDate>08/13/2008</EndDate>
      <RoleCode>Former Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>Marcia</FirstName>
      <LastName>Osburne</LastName>
      <EmailAddress>mosburne@mit.edu</EmailAddress>
      <StartDate>08/13/2008</StartDate>
      <EndDate/>
      <RoleCode>Principal Investigator</RoleCode>
    </Investigator>
    <Institution>
      <Name>EarthGenes Pharmaceuticals</Name>
      <CityName>Lexington</CityName>
      <ZipCode>024216651</ZipCode>
      <PhoneNumber>7818627209</PhoneNumber>
      <StreetAddress>107 Cedar St</StreetAddress>
      <CountryName>United States</CountryName>
      <StateName>Massachusetts</StateName>
      <StateCode>MA</StateCode>
    </Institution>
    <FoaInformation>
      <Code>0308000</Code>
      <Name>Industrial Technology</Name>
    </FoaInformation>
    <FoaInformation>
      <Code>0110000</Code>
      <Name>Technology Transfer</Name>
    </FoaInformation>
  </Award>
</rootTag>
